SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Government clears Biocon’s Rs 1060 crore proposal for setting up pharmaceutical plant

26 May 2016 Evaluate

Karnataka government has cleared proposal of Biocon’s Rs 1060 crore investment for setting up a pharmaceutical plant. The proposed plant will manufacture injectables, monoclonal, and anti-bodies vaccines and will generate jobs to 700 people. The plant will be set up at Jigani in Anekal taluka.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

417.60 -0.80 (-0.19%)
01-Jul-2026 12:31 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1869.25
Dr. Reddys Labs. 1340.65
Cipla 1451.00
Zydus Lifesciences 1109.35
Lupin 2400.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: